MindMed shareholders elect directors, approve auditor and employee share purchase plan

Definium Therapeutics, Inc.

Six director nominees elected with votes for ranging from 18.1M to 23.7M; broker non-votes 13.8M.
Appointment of KPMG LLP as auditor approved: 36.8M for, 0.8M withheld.
2024 Employee Share Purchase Plan approved: 23.4M for, 0.3M against, 0.2M abstain, 13.8M broker non-votes.
Quorum of 37.6M shares (52.4% of 71.9M outstanding) present at June 10 meeting.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.